Quest Laboratories Ltd Falls 9.89%: 6 Key Events Shaping This Volatile Week

4 May 2026: Lower Circuit Amid Heavy Selling Pressure

Quest Laboratories Ltd opened the week on a weak note, hitting its lower circuit limit with a 4.89% decline to close at Rs.144.10. This sharp fall came despite the broader Sensex rising 0.09% to 35,711.23, highlighting company-specific selling pressure. The stock’s fall was driven by panic selling and unfilled supply, triggering the circuit breaker at the 4.68% daily loss limit. Notably, the stock traded near its 52-week high of Rs.152.60 just days prior, indicating a sudden shift in sentiment.

Volume was moderate at 96,000 shares, but delivery volumes had surged significantly on 30 April, suggesting increased investor participation that may have contributed to heightened volatility. Despite the sell-off, the stock remained above key moving averages, signalling that the decline could be a short-term correction rather than a reversal of the uptrend. The company’s Mojo Score was 78.0, rated as a Buy, reflecting solid fundamentals amid the volatility.

5 May 2026: Continued Downtrend with Another Lower Circuit

The downward momentum intensified on 5 May as Quest Laboratories Ltd again hit the lower circuit, falling 4.89% to Rs.137.05. This maximum daily loss of 5.0% was triggered amid heavy selling and unfilled supply, with the stock underperforming both its sector and the Sensex, which declined marginally by 0.41%. Trading volume dipped to 73,200 shares, and delivery volumes fell by over 33%, indicating waning investor conviction.

Technically, the stock slipped below its 5-day moving average, signalling short-term weakness despite longer-term averages remaining intact. The downgrade of the Mojo Grade from Strong Buy to Buy on 30 April may have contributed to the cautious sentiment. The micro-cap stock’s market capitalisation stood at approximately Rs.224 crore, with liquidity sufficient for moderate trade sizes but vulnerable to volatility spikes.

6 May 2026: Upper Circuit Surge on Strong Buying Momentum

In a dramatic reversal, Quest Laboratories Ltd surged 4.93% to Rs.143.80 on 6 May, hitting the upper circuit limit amid robust buying interest. This 5.0% gain outpaced the Pharmaceuticals & Biotechnology sector’s 1.3% rise and the Sensex’s 0.46% increase, signalling renewed investor enthusiasm. The stock closed at the day’s high, supported by strong technical indicators above all key moving averages.

The surge coincided with an upgrade in the Mojo Score to 81.0 and a return to a Strong Buy rating on 5 May, reflecting improved fundamentals and positive market sentiment. However, delivery volumes declined sharply by 57%, suggesting that the rally was driven more by intraday speculative buying than sustained accumulation. The stock’s micro-cap status and liquidity constraints likely contributed to the pronounced price movement.

7 May 2026: Lower Circuit Hit Again Amid Renewed Selling Pressure

Quest Laboratories Ltd’s volatility continued on 7 May as it plunged 4.97% to Rs.136.65, triggering the lower circuit for the third time in the week. This maximum daily loss occurred despite the Pharmaceuticals & Biotechnology sector gaining 0.18% and the Sensex rising 0.26%, underscoring company-specific selling pressure. Trading volume increased to 132,000 shares, but delivery volumes declined by 18%, indicating reduced long-term investor confidence.

Technically, the stock fell below its 5-day moving average, signalling short-term bearish momentum, though it remained above longer-term averages. The recent upgrade to a Strong Buy Mojo Grade contrasts with the price weakness, highlighting the disconnect between fundamentals and market sentiment. The micro-cap’s market capitalisation was approximately Rs.224 crore, with liquidity sufficient but vulnerable to sharp swings.

8 May 2026: Week Closes with Another Lower Circuit Decline

The week ended on a weak note as Quest Laboratories Ltd fell 4.98% to Rs.129.85, hitting the lower circuit limit once more. This maximum daily loss contrasted with the Pharmaceuticals & Biotechnology sector’s 0.32% gain and the Sensex’s 0.50% decline, emphasising the stock’s underperformance. Trading volume rose to 91,200 shares, with delivery volumes down 6.86%, signalling continued investor caution.

Despite trading above its 20-day, 50-day, 100-day, and 200-day moving averages, the stock remained below the 5-day average, indicating short-term weakness. The micro-cap’s liquidity constraints and heightened volatility contributed to the sharp price swings. The company’s Mojo Score remained robust at 81.0 with a Strong Buy rating, reflecting solid fundamentals amid market turbulence.

Key Takeaways from the Week

The week’s price action for Quest Laboratories Ltd was characterised by extreme volatility, with four separate lower circuit hits and one upper circuit surge. This pattern reflects a market grappling with conflicting signals: strong fundamental mojo scores and valuation attractiveness contrasted by intense short-term selling pressure and liquidity constraints typical of micro-cap stocks.

Despite the sharp declines, the stock consistently traded above its longer-term moving averages, suggesting that the underlying uptrend remains intact. The upgrade of the Mojo Score to 81.0 and the Strong Buy rating on 5 May provided a positive fundamental backdrop, although delivery volumes declined, indicating reduced conviction among long-term holders.

Valuation metrics remain attractive relative to peers, with the company trading at reasonable P/E and EV multiples. However, the downgrade from very attractive to attractive valuation grade signals a narrowing margin of safety as the stock price advanced earlier in the year. Investors should be mindful of the micro-cap’s inherent volatility and liquidity limitations when assessing risk.

Conclusion: Navigating Volatility Amid Strong Fundamentals

Quest Laboratories Ltd’s week from 4 to 8 May 2026 exemplifies the challenges micro-cap stocks face in balancing strong fundamental credentials with market sentiment and liquidity dynamics. The stock’s 9.89% weekly decline against a 1.25% Sensex gain underscores company-specific pressures driving volatility. Multiple lower circuit hits highlight panic selling episodes, while the upper circuit surge reflects intermittent bursts of buying enthusiasm, often linked to rating upgrades.

Investors should approach the stock with a measured perspective, recognising the robust mojo score and valuation appeal while remaining cautious of short-term price swings and volume trends. Monitoring technical signals, delivery volumes, and sector developments will be crucial in assessing the stock’s trajectory in the coming weeks.

Limited Period Only. Get Started for only Rs. 16,999 - Get MojoOne for 2 Years + 1 Year Absolutely FREE! (72% Off) Get 72% Off →